BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  BioCardia Enters Agreement with BlueRock Therapeutics to Provide Enabling Catheter Biotherapeutic Delivery Product Candidates for BlueRock’s Cell Therapy to Treat Heart Failure

  BioCardia ® , Inc. [Nasdaq: BCDA], today announced that it has entered into an agreement with BlueRock Therapeutics LP for the delivery of BlueRock’s cell therapy product candidates for the treatment of heart failure utilizing BioCardia’s minimally invasive biotherapeutic delivery product candidates.

  August 24, 2022

   · 

  3 min read
• Pharm Country

  Cara Therapeutics to Host Virtual Notalgia Paresthetica Event on September 20, 2022

  Cara Therapeutics, Inc. today announced the Company will host a virtual event focused on notalgia paresthetica (NP) on Tuesday, September 20, 2022, from 11:00 a.m. to 12:15 p.m. ET.

  August 24, 2022

   · 

  2 min read
• Business

  BIO-TECHNE INCLUDED IN THE FORBES BEST-IN-STATE EMPLOYERS 2022 LIST

  Bio-Techne Corporation (NASDAQ: TECH) today announced that it has been included in the Forbes list of Best-in-State Employers 2022.

  August 24, 2022

   · 

  2 min read
• Compugen Expands anti-PVRIG COM701 Patent Portfolio with New Composition of Matter and Use Patent in Japan

  Compugen Ltd. announced today that the Japan Patent Office has granted Compugen a new composition of matter and use patent covering its potentially first-in-class anti-PVRIG, COM701 and backup anti-PVRIG antibodies.

  August 24, 2022

   · 

  5 min read
• Business

  Biotheryx Announces Appointment of Tracy Lawhon as Chief Development Officer

  Biotheryx, Inc. today announced the appointment of Tracy Lawhon, J.D., as Chief Development Officer (CDO).

  August 24, 2022

   · 

  3 min read
• Business

  Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2022 Financial Results

  Covalon Technologies Ltd. will release its Q3 Fiscal 2022 financial results on Monday, August 29th, 2022, before markets open.

  August 24, 2022

   · 

  3 min read
• Business

  Tessera Therapeutics Expands Leadership and Board

  Tessera Therapeutics, the biotechnology company pioneering GENE WRITING™ technology, today announced the appointment of Anne-Virginie Eggimann, M.Sc. as Chief Regulatory Officer (CRO) responsible for leading U.S. and global regulatory science and program.

  August 24, 2022

   · 

  7 min read
• Biotech Beach

  Glaukos Announces Participation in the Wells Fargo Healthcare Conference

  Glaukos Corporation today announced that its management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday, September 7, 2022, at 3:45 p.m. ET in Boston, MA.

  August 24, 2022

   · 

  1 min read
• Oragenics Announces Favorable Preliminary Toxicology Data for Intranasal COVID-19 Vaccine Candidate

  Oragenics, Inc. today announced favorable preliminary results from its ongoing Good Laboratory Practice (GLP) toxicology study to evaluate the safety profile and immunogenicity of its NT-CoV2-1 vaccine candidate in rabbits.

  August 24, 2022

   · 

  5 min read
• Lone Star Bio

  Castle Biosciences to Host Investor Day on Sept. 20, 2022

  Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will host an Investor Day on Sept. 20, 2022.

  August 24, 2022

   · 

  1 min read